RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D).

A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D).

Add to Collection
2021 Nov 11 Systematic Review and Meta Analysis Fist_Author_Year_PM

Full Author : ['Ghosal, Samit', 'Datta, Debasis', 'Sinha, Binayak']
Journal Title : Scientific reports
Chapter : Section3
Journal Year : 2021
Cited by : Not Available

Treatment options for nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D), two conditions which coexist, are limited though weight loss is an important strategy to improve outcomes in either disease. Glucagon-like peptide 1 receptor agonist.....

Keywords : ["nonalcoholic fatty liver disease nafld", "glucagonlikepeptide receptor agonist", "type diabetes", "metaanalysis", "effect"]